Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
£47m - Kromek's big take from shareholders
X-ray technology developer Kromek (KMK:AIM) has raised £47m from investors since IPO on 16 October 2013. Sadly, progress has been slow going and the current market value of the business stands at £33.8m, substantially below the £55m capitalisation when joining AIM. The Durham University spin-out still hopes to grow the business into several markets using its own patent-protected Cadmium Zinc Telluride (CZT) crystal technology. Contracts have been won with homeland security agencies for its nuclear radiation detection kit and there are applications in airport security and medical imaging markets to address. (SF)